Oncogene Proteins, Fusion
"Oncogene Proteins, Fusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin.
MeSH Number(s)
D12.776.602.500.500
D12.776.624.664.500
Concept/Terms
Oncogene Proteins, Fusion- Oncogene Proteins, Fusion
- Fusion Oncogene Proteins
- Proteins, Fusion Oncogene
- Oncogene Proteins, Chimeric
- Fusion Proteins, Oncogene
- Oncogene Fusion Proteins
- Proteins, Oncogene Fusion
- Chimeric Oncogene Proteins
- Proteins, Chimeric Oncogene
- Chimeric Proteins, Oncogene
- Oncogene Chimeric Proteins
- Proteins, Oncogene Chimeric
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins, Fusion".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins, Fusion".
This graph shows the total number of publications written about "Oncogene Proteins, Fusion" by people in Harvard Catalyst Profiles by year, and whether "Oncogene Proteins, Fusion" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 2 | 1 | 3 |
1996 | 1 | 1 | 2 |
1997 | 5 | 1 | 6 |
1998 | 5 | 0 | 5 |
1999 | 4 | 1 | 5 |
2000 | 8 | 3 | 11 |
2001 | 12 | 9 | 21 |
2002 | 12 | 7 | 19 |
2003 | 15 | 3 | 18 |
2004 | 10 | 6 | 16 |
2005 | 11 | 7 | 18 |
2006 | 14 | 6 | 20 |
2007 | 17 | 7 | 24 |
2008 | 13 | 3 | 16 |
2009 | 18 | 8 | 26 |
2010 | 16 | 10 | 26 |
2011 | 15 | 16 | 31 |
2012 | 14 | 14 | 28 |
2013 | 21 | 13 | 34 |
2014 | 22 | 17 | 39 |
2015 | 18 | 11 | 29 |
2016 | 32 | 16 | 48 |
2017 | 29 | 9 | 38 |
2018 | 22 | 25 | 47 |
2019 | 20 | 18 | 38 |
2020 | 27 | 24 | 51 |
2021 | 19 | 26 | 45 |
2022 | 6 | 33 | 39 |
2023 | 3 | 19 | 22 |
2024 | 0 | 3 | 3 |
Below are the most recent publications written about "Oncogene Proteins, Fusion" by people in Profiles.
-
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression. J Natl Cancer Inst. 2024 Mar 07; 116(3):421-433.
-
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. J Exp Med. 2024 Mar 04; 221(3).
-
The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture. Cancer Res. 2024 01 16; 84(2):241-257.
-
Cancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor Microenvironment. Clin Cancer Res. 2023 Dec 15; 29(24):5140-5154.
-
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma. Cancer Res. 2023 12 01; 83(23):3846-3860.
-
ETV6 fusions from insertions of exons 3-5 in pediatric hematologic malignancies. Haematologica. 2023 Dec 01; 108(12):3471-3476.
-
Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls. Histopathology. 2024 Feb; 84(3):451-462.
-
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1436-1443.
-
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas. Cancer. 2023 12 01; 129(23):3772-3782.
-
DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma. Mod Pathol. 2023 11; 36(11):100301.